Early Warnings of Disease.
Early-detection devices for chronic diseases play an integral role in lowering healthcare costs and improving patient survival rates. DiagnosMe is a new venture in which a team of undergraduates has built a color-based test for a specific protein found in sweat. The protein is correlated with chronic diseases and is a marker of immune system activity. It is found at very low levels in healthy patients, and jumps ten-fold in patients with chronic diseases.
The current state of the art testing for the protein is lab-based and requires expensive shipping and analysis procedures. DiagnosMe bridges the gap between user and results by bringing the test right into the user's home. The purpose of the device is to detect illnesses early in their development by enabling users to monitor levels of this protein in their sweat over time using a sweat collection device and a smartphone application. If a user experiences a sustained elevated level of this protein for many weeks, he or she is advised by the smartphone application to see a physician for proper symptomatic diagnosis and monitoring. The team's ultimate vision for DiagnosMe is to create biosensors for many specific chronic diseases associated with this protein family, and to provide convenient analysis for high-risk or in-remission patients. In addition, the team is working to create a device that will give users an even broader view of their health by incorporating components such as the user's cellular device, a heart rate monitor, thermometer, pedometer, and blood pressure measurement device.
The device thus far has been tested on one of these proteins and is both accurate and precise with respect to the state of the art lab-based test. In addition, the device was able to detect changes in the immune systems of individuals diagnosed with the flu. The future of telemedicine is focused on integrating the patient with modern diagnostic techniques and their smartphones. DiagnosMe is part of the telemedicine movement because it allows users to utilize innovative new diagnostic procedures along with their smartphones in order to monitor their health. DiagnosMe has been registered as an LLC, and the technology is patent-pending. The device has been built and tested as an immune system protein monitoring and diagnostic system that will help users catch chronic diseases earlier, with the hope of improving the prevention and treatment of disease.
Kiah Williams, Chief Executive Officer
Kiah Williams is the Chief Executive Officer of DiagnosMe and is studying Human Biology and Hispanic Studies at Dartmouth College. She plans to enter into an M.D./Ph.D. program after
graduating and hopes to become a cardiac surgeon. Kiah is involved in multiple medical research projects at Dartmouth and in her home state of Colorado. Kiah has worked in retail, sales, management, marketing, teaching, and research. She was a top-performing branch founder and manager for Revolution Prep in 2012, and is a Sophomore Science Scholar at Dartmouth for her research on how cardiopulmonary bypass causes brain injury. This research includes the first use of a mouse model for cardiopulmonary bypass.
Rob Lauzen, Chief Operating Officer
Rob is the Chief Operating Officer of DiagnosMe and is a sophomore at Dartmouth College studying Engineering with a focus in Biology. He is interested in the convergence of cutting-edge biomedical and healthcare technologies and ideas with global capital. Rob has a background in a wide range of industries through internships with Cypress Semiconductor in San Jose, CA, MacLean-Fogg Component Solutions in Krefeld, Germany, and National Financial Partners in New York, NY. Each experience has provided a different perspective and approach to engineering and management. Outside of the classroom, he is a member of the Dartmouth varsity football team.
Katherine Franklin, Chief Scientific Officer
Katherine is the Chief Scientific Officer of DiagnosMe. Katherine is a sophomore at Dartmouth College studying biomedical engineering with the intention of pursuing a PhD after graduation. She has experience in both a multimodal neuroimaging lab and an orthopedics lab. Her work in the brain imaging lab led her to conduct a one year independent research project focusing on traumatic brain injury in soldiers. Her work in the orthopedics lab over the past five years has produced many research abstracts accepted by the Orthopedic Research Society. In addition to classes and research, Katherine has experience working in retail, has volunteered as a tutor to her peers, holds a leadership role as an Undergraduate Advisor, and is a board member of the nonprofit Nepalese Children's Health and Education Foundation.
Riley Ennis, VP Clinical Development
Riley is the Senior Vice President of Clinical Development at DiagnosMe. Riley previously founded a biotechnology startup, Immudicon LLC. He worked for three years on a cancer vaccine technology that teaches the immune cells of the body to recognize and remove tumors. He worked to receive over $10,000 in initial funding to start Immudicon, which is focused on licensing the cancer vaccine platform technology. The vaccine has been recognized by the GE Focus Forward Competition, the Intel International Science Fair, the BioGENEius Challenge, AXA Equitable Achievement Award, National Young Inventors Gallery, and the Virginia Academy of Science. Riley is currently a sophomore at Dartmouth College and wants to double major in economics and biology.